Evidence map›Paper›PMID 25537708›Full record

GuidelineDiabetes care2015

(8) Cardiovascular disease and risk management.

American Diabetes Association

2 registry-linked trialsAbstract readPractice Guideline
PubMed Publisher
In one paragraph

Guideline in Diabetes care, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 99 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03696940 phase3unknown statusstarted 2018, after this paper: background citation

Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina

Ran2018Enrolled120Registered outcomes6Posted comparisons0ConditionsCardiovascular Risk Factor, DyslipidemiasArmsAtorvastatin 10mg, L-Carnitine 500Mg Oral Tablet + Atorvastatin 10 mg
PMID 27046161PMID 24793440PMID 24793441PMID 24793443PMID 16034009PMID 26939026PMID 17039901PMID 23190071PMID 19604523PMID 25915661PMID 19618992PMID 16384561other papers from this trial
Open the trial in the graph
NCT03579108 unknown statusnot on this mapstarted 2018, after this paper: background citation

Hypertension Management and Outcomes in a Family Practice Setting

TypeobservationalSponsorLouisiana State University Health Sciences Center in New OrleansRan2018 to 2024Enrolled200ConditionsHypertensionArmsRetrospective Chart Review
3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Review
  13. Lipid management strategies for diabetic patients align with an evidence-based guideline.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Nutraceutic Potential of Bioactive Compounds ofMolecules (Basel, Switzerland) · 2022
    Review
  19. Review
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

American Diabetes Association

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Risk Reduction BehaviorAntihypertensive AgentsCardiovascular DiseasesCoronary DiseaseDiabetes ComplicationsDiabetes MellitusDisease ManagementDyslipidemiasFibric AcidsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypertensionHypolipidemic AgentsNiacinPlatelet Aggregation InhibitorsAntihypertensive AgentsFibric AcidsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsNiacinPlatelet Aggregation Inhibitors

Identifiers

PMID25537708

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.